Copyright Reports & Markets. All rights reserved.

Global Gene Editing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gene Editing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gene Editing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Zinc finger nucleases (ZFNs)
    • 1.4.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
    • 1.4.4 CRISPR-Cas system
  • 1.5 Market by Application
    • 1.5.1 Global Gene Editing Market Share by Application: 2020 VS 2026
    • 1.5.2 Biotechnology & Pharmaceutical Companies
    • 1.5.3 Academic & Government Research Institutes
    • 1.5.4 Contract Research Organizations
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Gene Editing Market Perspective (2015-2026)
  • 2.2 Global Gene Editing Growth Trends by Regions
    • 2.2.1 Gene Editing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gene Editing Historic Market Share by Regions (2018-2019)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Competition Landscape by Key Players

  • 3.1 Gene Editing Revenue by Players (2019-2020)
  • 3.2 Gene Editing Key Players Head office and Area Served
  • 3.3 Key Players Gene Editing Product/Solution/Service
  • 3.4 Date of Enter into Gene Editing Market
  • 3.5 Key Players Gene Editing Funding/Investment Analysis
  • 3.6 Global Key Players Gene Editing Valuation & Market Capitalization
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Global Gene Editing Market Size by Type (2019-2026)

    5 Global Gene Editing Market Size by Application (2019-2026)

      6 North America

      • 6.1 North America Gene Editing Market Forecast (2019-2026)
      • 6.2 Gene Editing Key Players in North America (2019-2020)
      • 6.3 North America Gene Editing Market Size by Type (2015-2020)
      • 6.4 North America Gene Editing Market Size by Application (2015-2020)

      7 Europe

      • 7.1 Europe Gene Editing Market Forecast (2019-2026)
      • 7.2 Gene Editing Key Players in Europe (2019-2020)
      • 7.3 Europe Gene Editing Market Size by Type (2015-2020)
      • 7.4 Europe Gene Editing Market Size by Application (2015-2020)

      8 China

      • 8.1 China Gene Editing Market Forecast (2019-2026)
      • 8.2 Gene Editing Key Players in China (2019-2020)
      • 8.3 China Gene Editing Market Size by Type (2015-2020)
      • 8.4 China Gene Editing Market Size by Application (2015-2020)

      9 Japan

      • 9.1 Japan Gene Editing Market Forecast (2019-2026)
      • 9.2 Gene Editing Key Players in Japan (2019-2020)
      • 9.3 Japan Gene Editing Market Size by Type (2015-2020)
      • 9.4 Japan Gene Editing Market Size by Application (2015-2020)

      10 Southeast Asia

      • 10.1 Southeast Asia Gene Editing Market Forecast (2019-2026)
      • 10.2 Gene Editing Key Players in Southeast Asia (2019-2020)
      • 10.3 Southeast Asia Gene Editing Market Size by Type (2015-2020)
      • 10.4 Southeast Asia Gene Editing Market Size by Application (2015-2020)

      11 India

      • 11.1 India Gene Editing Market Forecast (2019-2026)
      • 11.2 Gene Editing Key Players in India (2019-2020)
      • 11.3 India Gene Editing Market Size by Type (2015-2020)
      • 11.4 India Gene Editing Market Size by Application (2015-2020)

      12 Central & South America

      • 12.1 Central & South America Gene Editing Market Forecast (2019-2026)
      • 12.2 Gene Editing Key Players in Central & South America (2019-2020)
      • 12.3 Central & South America Gene Editing Market Size by Type (2015-2020)
      • 12.4 Central & South America Gene Editing Market Size by Application (2015-2020)

      13 Key Players Profiles

      • 13.1 Thermo Fisher Scientific
        • 13.1.1 Thermo Fisher Scientific Company Details
        • 13.1.2 Thermo Fisher Scientific Business Overview
        • 13.1.3 Thermo Fisher Scientific Gene Editing Introduction
        • 13.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2020))
        • 13.1.5 Thermo Fisher Scientific Recent Development
      • 13.2 Merck
        • 13.2.1 Merck Company Details
        • 13.2.2 Merck Business Overview
        • 13.2.3 Merck Gene Editing Introduction
        • 13.2.4 Merck Revenue in Gene Editing Business (2019-2020))
        • 13.2.5 Merck Recent Development
      • 13.3 Horizo​​n Discovery
        • 13.3.1 Horizo​​n Discovery Company Details
        • 13.3.2 Horizo​​n Discovery Business Overview
        • 13.3.3 Horizo​​n Discovery Gene Editing Introduction
        • 13.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2019-2020))
        • 13.3.5 Horizo​​n Discovery Recent Development
      • 13.4 Sangamo BioSciences
        • 13.4.1 Sangamo BioSciences Company Details
        • 13.4.2 Sangamo BioSciences Business Overview
        • 13.4.3 Sangamo BioSciences Gene Editing Introduction
        • 13.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2019-2020))
        • 13.4.5 Sangamo BioSciences Recent Development
      • 13.5 Integrated DNA Technologies
        • 13.5.1 Integrated DNA Technologies Company Details
        • 13.5.2 Integrated DNA Technologies Business Overview
        • 13.5.3 Integrated DNA Technologies Gene Editing Introduction
        • 13.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2019-2020))
        • 13.5.5 Integrated DNA Technologies Recent Development
      • 13.6 Lonza
        • 13.6.1 Lonza Company Details
        • 13.6.2 Lonza Business Overview
        • 13.6.3 Lonza Gene Editing Introduction
        • 13.6.4 Lonza Revenue in Gene Editing Business (2019-2020))
        • 13.6.5 Lonza Recent Development
      • 13.7 New England Biolabs
        • 13.7.1 New England Biolabs Company Details
        • 13.7.2 New England Biolabs Business Overview
        • 13.7.3 New England Biolabs Gene Editing Introduction
        • 13.7.4 New England Biolabs Revenue in Gene Editing Business (2019-2020))
        • 13.7.5 New England Biolabs Recent Development
      • 13.8 OriGene Technologies
        • 13.8.1 OriGene Technologies Company Details
        • 13.8.2 OriGene Technologies Business Overview
        • 13.8.3 OriGene Technologies Gene Editing Introduction
        • 13.8.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
        • 13.8.5 OriGene Technologies Recent Development
      • 13.9 Transposagen Biopharmaceuticals
        • 13.9.1 Transposagen Biopharmaceuticals Company Details
        • 13.9.2 Transposagen Biopharmaceuticals Business Overview
        • 13.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
        • 13.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2020))
        • 13.9.5 Transposagen Biopharmaceuticals Recent Development
      • 13.10 Editas Medicine
        • 13.10.1 Editas Medicine Company Details
        • 13.10.2 Editas Medicine Business Overview
        • 13.10.3 Editas Medicine Gene Editing Introduction
        • 13.10.4 Editas Medicine Revenue in Gene Editing Business (2019-2020))
        • 13.10.5 Editas Medicine Recent Development
      • 13.11 CRISPR Therapeutics
        • 10.11.1 CRISPR Therapeutics Company Details
        • 10.11.2 CRISPR Therapeutics Business Overview
        • 10.11.3 CRISPR Therapeutics Gene Editing Introduction
        • 10.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2019-2020))
        • 10.11.5 CRISPR Therapeutics Recent Development
      • 13.12 RGen Solutions
        • 10.12.1 RGen Solutions Company Details
        • 10.12.2 RGen Solutions Business Overview
        • 10.12.3 RGen Solutions Gene Editing Introduction
        • 10.12.4 RGen Solutions Revenue in Gene Editing Business (2019-2020))
        • 10.12.5 RGen Solutions Recent Development
      • 13.13 Sigma-Aldrich
        • 10.13.1 Sigma-Aldrich Company Details
        • 10.13.2 Sigma-Aldrich Business Overview
        • 10.13.3 Sigma-Aldrich Gene Editing Introduction
        • 10.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2019-2020))
        • 10.13.5 Sigma-Aldrich Recent Development
      • 13.14 GeneCopoeia
        • 10.14.1 GeneCopoeia Company Details
        • 10.14.2 GeneCopoeia Business Overview
        • 10.14.3 GeneCopoeia Gene Editing Introduction
        • 10.14.4 GeneCopoeia Revenue in Gene Editing Business (2019-2020))
        • 10.14.5 GeneCopoeia Recent Development
      • 13.15 Genscript Biotech
        • 10.15.1 Genscript Biotech Company Details
        • 10.15.2 Genscript Biotech Business Overview
        • 10.15.3 Genscript Biotech Gene Editing Introduction
        • 10.15.4 Genscript Biotech Revenue in Gene Editing Business (2019-2020))
        • 10.15.5 Genscript Biotech Recent Development
      • 13.16 OriGene Technologies
        • 10.16.1 OriGene Technologies Company Details
        • 10.16.2 OriGene Technologies Business Overview
        • 10.16.3 OriGene Technologies Gene Editing Introduction
        • 10.16.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
        • 10.16.5 OriGene Technologies Recent Development
      • 13.17 Agilent Technologies
        • 10.17.1 Agilent Technologies Company Details
        • 10.17.2 Agilent Technologies Business Overview
        • 10.17.3 Agilent Technologies Gene Editing Introduction
        • 10.17.4 Agilent Technologies Revenue in Gene Editing Business (2019-2020))
        • 10.17.5 Agilent Technologies Recent Development

      14 Market Dynamics

      • 14.1 Drivers
      • 14.2 Challenges
      • 14.3 Porter’s Five Forces Analysis
      • 14.4 Market Ecosystem and Value Chain Analysis

      15 Key Findings in This Report

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Global Gene Editing Scope and Market Size
      Gene Editing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      The key players covered in this study
      Thermo Fisher Scientific
      Merck
      Horizo​​n Discovery
      Sangamo BioSciences
      Integrated DNA Technologies
      Lonza
      New England Biolabs
      OriGene Technologies
      Transposagen Biopharmaceuticals
      Editas Medicine
      CRISPR Therapeutics
      RGen Solutions
      Sigma-Aldrich
      GeneCopoeia
      Genscript Biotech
      OriGene Technologies
      Agilent Technologies

      Market segment by Type, the product can be split into
      Zinc finger nucleases (ZFNs)
      Transcription Activator-Like Effector-based Nucleases (TALENs)
      CRISPR-Cas system
      Market segment by Application, split into
      Biotechnology & Pharmaceutical Companies
      Academic & Government Research Institutes
      Contract Research Organizations

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America
      Buy now